240 related articles for article (PubMed ID: 37815872)
1. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
[TBL] [Abstract][Full Text] [Related]
2. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
[TBL] [Abstract][Full Text] [Related]
3. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.
Zarrilli G; Galuppini F; Angerilli V; Munari G; Sabbadin M; Lazzarin V; Nicolè L; Biancotti R; Fassan M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807389
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Xue J; Jia E; Ren N; Xin H
Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
[TBL] [Abstract][Full Text] [Related]
5. ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Tungekar A; Mandarthi S; Mandaviya PR; Gadekar VP; Tantry A; Kotian S; Reddy J; Prabha D; Bhat S; Sahay S; Mascarenhas R; Badkillaya RR; Nagasampige MK; Yelnadu M; Pawar H; Hebbar P; Kashyap MK
Sci Rep; 2018 Aug; 8(1):12715. PubMed ID: 30143675
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.
Yang B; Liu Y; Li L; Deng H; Xian L
Mol Med Rep; 2020 May; 21(5):2073-2084. PubMed ID: 32323771
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
8. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.
Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF
Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691
[TBL] [Abstract][Full Text] [Related]
9. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
[TBL] [Abstract][Full Text] [Related]
10. Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
Fang Y; Chen X; Bajpai M; Verma A; Das KM; Souza RF; Garman KS; Donohoe CL; O'Farrell NJ; Reynolds JV; Dvorak K
Ann N Y Acad Sci; 2013 Oct; 1300():187-199. PubMed ID: 24117642
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Kan T; Meltzer SJ
Curr Opin Pharmacol; 2009 Dec; 9(6):727-32. PubMed ID: 19773200
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
[TBL] [Abstract][Full Text] [Related]
14. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
15. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G
Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
17. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Smith CM; Watson DI; Michael MZ; Hussey DJ
World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019
[TBL] [Abstract][Full Text] [Related]
19. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
